Belite Bio, Inc. ADR (BLTE) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Belite Bio, Inc. ADR (BLTE) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Belite Bio, Inc. ADR

· BLTE

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

6.839 B

-2.10%

General

Market Cap: $6.84B
Enterprise Value: $6.4B
Shares Outstanding: 40,090,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -12.93%
ROE: -15.65%
ROIC: -15.28%
Current Ratio: 33.56
Debt-to-Equity: —
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.78
P/S: —
P/FCF: —
P/B: 8.24
EV/EBITDA: -56.00

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $118.69M
Operating Income: -$118.69M
Net Profit: -$102.36M

Balance Sheet

Cash and Equivalents: —
Working Capital: $486.65M
Total Assets: $791.58M
Net Debt: —
Total Liabilities: $14.95M
Total Equity: $776.64M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$10.39K
Cash Flow from Investing: -$303.73K
Cash Flow from Financing: $510.12K
Free Cash Flow: -$10.56K
Capital Expenditures: $178